-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AQWxWQrA+Iaqp8cRtrK9tlNKli/jWFQJjMeGLar1+5LqHYAQL7O+5QVJ1kyAV+WX s7jLG56qkKyj8vnCx3+d6Q== 0001209191-07-071440.txt : 20071221 0001209191-07-071440.hdr.sgml : 20071221 20071221160050 ACCESSION NUMBER: 0001209191-07-071440 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071220 FILED AS OF DATE: 20071221 DATE AS OF CHANGE: 20071221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHLEIFER LEONARD S CENTRAL INDEX KEY: 0001218629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 071323187 BUSINESS ADDRESS: STREET 1: C/O REGENERON PHARMACEUTICALS INC STREET 2: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143457400 4 1 bny45275_ls.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-12-20 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001218629 SCHLEIFER LEONARD S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 1 0 Chief Exec Officer & President Common Stock 2007-12-20 4 M 0 37370 8.625 A 93917 D Common Stock 2007-12-20 4 F 0 14466 22.28 D 79451 D Common Stock 2007-12-20 4 F 0 7741 22.28 D 71710 D Common Stock 4028 I By 401(k) Plan Common Stock 900 I By Son Non-Qualified Stock Options (right to buy) 8.625 2007-12-20 4 M 0 37370 D 2008-01-01 Common Stock 37370 0 D Class A Stock Common Stock 1710790 1710790 D Class A Stock Common Stock 29275 29275 I By Son Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). This stock option was granted on January 1,1998 and became exercisable in five equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**Leonard S. Schleifer 2007-12-20 -----END PRIVACY-ENHANCED MESSAGE-----